Bill tracker, H.R. 1051, Health
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
- Introduced
- In committee
- Reported
- Passed the House
- Passed the Senate
- To the President
- Became law
Introduced Feb 6, 2025. Latest action Feb 6, 2025: Referred to the House Committee on Energy and Commerce.
Sponsor
Committees
- Energy and Commerce Committee
Referred To Feb 6, 2025
Timeline
What happened to it
- No major action since Feb 6, 2025 (21 months)Last step: Introduced
Full history
- ReferredHouse. Referred to the House Committee on Energy and Commerce.
- IntroducedIntroduced in House
